在重症监护室的皮质类固醇是否具有免疫抑制作用? 反思和假设的反映和假设
1Service de réanimation chirurgicale polyvalente, Sorbonne University, GRC 29, AP-HP, DMU DREAM and Department of Anaesthesiology and Critical Care, Pitié-Salpêtrière Hospital, 47-83 Bd de l'Hôpital, 75013 Paris, France.
在重症监护中,皮质类固醇可能并不总是免疫抑制剂. 本综述探讨了新的假设,表明它们的作用比以前认为的更加复杂和上下文依赖,特别是在急性炎症条件下.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 皮质类固醇广泛用于急性炎症状况,如ARDS和败血症休克.
- 它们被归类为免疫抑制剂以及与感染风险的关联是有争议的.
研究的目的:
- 重新考虑在重症监护中的皮质类固醇的分类.
- 探索除了免疫抑制之外的替代机制.
- 挑战对皮质类固醇作用的传统,简单的观点.
主要方法:
- 文献综述 文献综述 文献综述
- 重新考虑现有的数据.
- 探索替代机械学假设的探索.
主要成果:
- 传统的视角类固醇作为免疫抑制剂的观点可能过于简单.
- 在急性炎症情形下,皮质类固醇的影响可能取决于情境.
结论:
- 需要进一步的研究来了解皮质类固醇的细微作用.
- 对在重症监护中的皮质类固醇来说,上下文依赖的分类可能更合适.
- 免疫抑制模式可能无法完全捕捉ARDS和败血症休克中皮质类固醇的影响.
更多相关视频
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cell-mediated Immune Responses
